Oragenics Inc (OGEN)
0.3300 +0.0042 (1.29%)
Oragenics Inc is a biotechnology company focused on the development of innovative solutions for infectious diseases and oral health. The company is primarily engaged in creating novel antibiotics and therapeutics, particularly against multi-drug resistant pathogens, as well as products aimed at enhancing oral health through advanced microbial therapies. Oragenics leverages its proprietary technologies and research capabilities to address significant medical needs, with a mission to improve patient outcomes and combat rising antibiotic resistance through targeted and effective treatment options.
Why Grab Holdings Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · November 12, 2024
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · October 14, 2024
EXCLUSIVE: Oragenics Completes Key FDA-Recognized Study For Concussion Drug Candidatebenzinga.com
Oragenics completed a key study showing its nasal spray drug ONP-002 effectively targets brain-related nasal areas, setting the stage for Phase 2 trials in concussion treatment.
Via Benzinga · October 8, 2024
Why DocuSign Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · October 8, 2024
Why Oragenics (OGEN) Stock Is Getting Hammeredbenzinga.com
Oragenics shares are trading lower by 47% during Wednesday's session. The company announced a $4.45 million public offering.
Via Benzinga · September 4, 2024
OGEN Stock Earnings: Oragenics Reported Results for Q2 2024investorplace.com
Oragenics just reported results for the second quarter of 2024.
Via InvestorPlace · August 12, 2024
OGEN Stock Earnings: Oragenics Reported Results for Q4 2023investorplace.com
Oragenics just reported results for the fourth quarter of 2023.
Via InvestorPlace · June 28, 2024
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · October 7, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · September 25, 2024
Crude Oil Down 1%; Dollar Tree Shares Tumble After Downbeat Earningsbenzinga.com
Via Benzinga · September 4, 2024
Why GitLab Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · September 4, 2024
Why Oragenics (OGEN) Shares Are Fallingbenzinga.com
Oragenics shares are trading lower by 21% during Tuesday's session. The company announced pricing of its public offering.
Via Benzinga · June 25, 2024
OGEN Stock Earnings: Oragenics Reported Results for Q1 2024investorplace.com
Oragenics just reported results for the first quarter of 2024.
Via InvestorPlace · May 15, 2024
EXCLUSIVE: Oragenics Completes Spray Dry Drug Manufacturing, Intranasal Device Filling For Anticipated Mid-Stage Study For Patients With Brain Injurybenzinga.com
Oragenics completes the formulation and filling of its nasal spray drug, ONP-002, for concussion treatment, aiming to launch a Phase 2a trial.
Via Benzinga · August 21, 2024
EXCLUSIVE: Oragenics' Concussion Drug Clears FDA-Required Cardiotoxicity Testing, Planning For Phase Trials Underwaybenzinga.com
Oragenics announced its lead candidate, ONP-002, for treating concussion, which shows no cardiotoxicity in studies. Designed for nasal delivery to the brain, ONP-002 aims to address the significant unmet medical need for concussion treatment.
Via Benzinga · August 8, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesdayinvestorplace.com
Pre-market stock movers are worth checking out on Tuesday as we get into all of the hottest news worth reading about this morning!
Via InvestorPlace · June 25, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · June 5, 2024
Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Sessionbenzinga.com
Via Benzinga · May 22, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · May 22, 2024